news – Page 3533 – pharmaceutical daily

October 19, 2016 Off

SuperSonic reports 10% revenue growth

SuperSonic Imagine has announced its sales for the third quarter to September 30, 2016.

October 19, 2016 Off

Keopsys group makes changes in Quantel’s Board

By Dino Mustafić

KEOPSYS Group holding company, acquired for € 5 million, 93.8% of the capital of EURODYNE, which holds 1,184,513 QUANTEL shares and 1,928,579 voting rights, representing 14.6% of the capital and 21.3% of the voting rights of QUANTEL.

October 19, 2016 Off

JNJ sales went up, net income $4,272M in Q3 2016

By Dino Mustafić

Johnson & Johnson has reported on Tuesday net earnings and diluted earnings per share for the third quarter of 2016 of$4.3 billion and $1.53, respectively. Third quarter 2015 net earnings included …

October 19, 2016 Off

EMA’s CHMP reccomends Teva’s Trisenox indication extension

By Dino Mustafić

Teva Pharmaceutical has gotten a positive opinion from Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), recommending an indication extension of Trisenox (arsenic trioxide).

October 19, 2016 Off

Allergan releases its “lip pumping drug” to the US market

By Dino Mustafić

Allergan has announced that the latest addition to the Juvederm collection of fillers, Juvederm Volbella XC, is now available to physicians and patients for use in the lips for lip augmentation and for correction of perioral rhytids, commonly referred to as “lipstick lines”, in adults over the age of 21.